Skip to content

Drug interactions

Nicardipine + Paclitaxel protein bound

Severity: Minor

Nicardipine and Paclitaxel protein bound: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nicardipine can inhibit P-glycoprotein and is a CYP3A4 substrate or inhibitor, which could increase paclitaxel exposure. Higher paclitaxel levels may increase neutropenia and neuropathy, though clinical evidence is limited.

What this interaction means in plain words

Nicardipine and Paclitaxel protein bound have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Possible P-glycoprotein inhibition by nicardipine reduces paclitaxel efflux and clearance.

What to do

No empirical dose change is required. Monitor blood counts and signs of neuropathy as part of routine paclitaxel care.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nicardipine and Paclitaxel protein bound, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Nicardipine with Paclitaxel protein bound?

MediHelp rates the interaction as minor. Nicardipine and Paclitaxel protein bound have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Nicardipine can inhibit P-glycoprotein and is a CYP3A4 substrate or inhibitor, which could increase paclitaxel exposure. Higher paclitaxel levels may increase neutropenia and neuropathy, though clinical evidence is limited.

How serious is the interaction between Nicardipine and Paclitaxel protein bound?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose change is required. Monitor blood counts and signs of neuropathy as part of routine paclitaxel care.

What other medicines interact with Nicardipine?

MediHelp also lists interactions of Nicardipine with, for example, Amifostine, Amlodipine-olmesartan-hydrochlorothiazide, Betrixaban. The full list is on the Nicardipine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in